Bob Bradway

As we close out another successful year, I want to thank my Amgen colleagues around the world for your hard work and your commitment to our mission to serve patients.I can’t wait to see what we’ll ...

The FDA’s approval of Amgen’s new treatment for adults living with anti-AChR or anti-MuSK Ab+ generalized myasthenia gravis (hashtag#gMG) marks a meaningful step in our mission to serve patients. ...

Recently, we had the opportunity to hear from Dr. Brian Druker, pioneer of targeted cancer therapy and longtime member of Amgen's Board of Directors, who spoke to employees across our global networ...

On this Veterans Day, I want to extend my heartfelt gratitude to all who have served in the U.S. military. Your courage, dedication, and sacrifice protect the freedoms we hold dear.At Amgen, we’re ...

This achievement reflects more than a decade of scientific commitment and collaboration at Amgen. It underscores the importance of early intervention and sustained LDL-C lowering to help prevent fi...